Skip to main content

Research at Alzheimer Society of Canada

1-855-705-4636
  • Find a Research Study
  • FAQs
  • Legal Disclaimer
  • Contact Us
  • Français

Alzheimer Society of Canada

Find a Research Study

Communication Bridge 3 (CB3) Clinical Trial

What is this Study about?

Who?
Individuals with a diagnosis of Primary Progressive Aphasia and their Communication Partners.

Why?
Researchers at the University of Chicago - Healthy Aging & Alzheimer's Research Care Center and Western University - Ontario want to develop evidence-based strategies to maximize communication participation and quality of life and minimize burden of persons with PPA and their communication partners.

What Will Happen in This Study?

Where?
All components of the study take place remotely via telehealth.

How Long?
Over the course of 18 months, participants in the study will be involved in:

Up to 10 evaluations with a licensed speech language therapist
Up to 25 therapy sessions with a speech language therapist
Exercises through a web-application

Who is Eligible to Participate in this Study?

You are eligible to participate if you speak English as a primary language, a confirmed diagnosis of PPA in mild to moderate impairment stage, a communication partner that is willing to participate, and sufficient internet connection.

Get in Touch About this Study

Legal Disclaimer

Any materials or links provided herein are strictly for informational purposes only. The Alzheimer Society of Canada does not endorse nor recommend any of the manufacturers, products or institutions mentioned in any of these links or listings as suitable or appropriate for your particular situation or circumstances and disclaims any liability with respect to representations, warranties, including fitness for an intended particular use or purpose, and all other claims relating thereto, all of which remain strictly with the manufacturer or institution.

In no event shall the Alzheimer Society of Canada or any third parties mentioned on the website be liable for any damage (including, without limitation, incidental and consequential damages for personal injury/wrongful death, lost profits or damages resulting from lost data or business interruption) or personal injury (including death) resulting from the use, misuse or inability to use any activity, product or service mentioned herein, whether based in warranty, contract, tort or any other legal theory.

Everyone considering participating in any activity is encouraged to speak with their own doctor or health-care team before participating in any activity that may impact their health or well-being.

Clinical Trial

Target Population

Caregivers, Person living with Alzheimer’s disease

Target Age Group(s)

66+

Study Location

Online
Ontario

Study Contact

Matthew Bona
Operations Manager
Western University - Ontario

Recruitment Start Date

July 15, 2024

Recruitment End Date

November 8, 2028
  • Learn more about observational studies
  • Learn more about clinical trials
  • Brain donations
  • More useful links and resources

Alzheimer Society of Canada logo

Alzheimer Society of Canada
20 Eglinton Avenue West, 16th Floor
Toronto, Ontario M4R 1K8
Information and Referral Line: 1-855-705-4636
Email: [email protected]

Charity registration number: 11878 4925 RR0001

Follow us:

  • Find us on Facebook
  • Follow us on Twitter
  • Follow us on Instagram
  • Subscribe to us on YouTube
  • Find us in LinkedIn

©2022 Alzheimer Society of Canada. All rights reserved.